SWOG clinical trial number
SWOG-7435

Piperazineclione (Crystalline Antibiotic) for Patients with Malignant Lymphoma or Multiple Myeloma

Closed
Abbreviated Title
Piperazineclione (Crystalline Antibiotic) for Patients with Malignant Lymphoma or Multiple Myeloma
Activated
12/27/1974
Closed
10/21/1976

Publication Information Expand/Collapse

1977

Phase II trial of piperazinedione in Hodgkin's disease, non-Hodgkin's lymphoma, and multiple myeloma: a Southwest Oncology Group study

SE Jones;WG Tucker;A Haut;BL Tranum;C Vaughn;EM Chase;BGM Durie Cancer Treat Rep 61:1617-1621

1976

Phase II trial of piperazinedione (crystalline antibiotic) in lymphoma and multiple myeloma.

S Jones;S Salmon;members of AACR, #179

Phase II trial of piperazinedione (crystalline antibiotic) in lymphoma and multiple myeloma.

S Jones;S Salmon;members of AACR, #179